Weimar Christian, Kurth Tobias, Kraywinkel Klaus, Wagner Markus, Busse Otto, Haberl Roman Ludwig, Diener Hans-Christoph
Department of Neurology, University of Essen, Essen, Germany.
Stroke. 2002 Aug;33(8):2053-9. doi: 10.1161/01.str.0000022808.21776.bf.
Functioning and disability after ischemic stroke are clinically meaningful and of major relevance to patients. Despite many instruments available to assess these outcomes, little is known about their interrelation and predictive factors.
We prospectively identified 4264 patients with acute ischemic stroke from 30 hospitals in Germany during a 1-year period between 1998 and 1999 and registered them in a common data bank. The patients were centrally followed up via telephone interview after 100 days and 1 year to assess various scales such as the Barthel Index (BI), modified Rankin Scale (MRS), extended Barthel Index (EBI), Short Form-36 Physical Functioning (SF-36 PF), and Center for Epidemiologic Studies-Depression short form (CES-D).
Outcome status could be assessed in 67.2% of patients 100 days after hospital admission. Of these, 13.9% had died, 53.7% had regained functional independence (BI <95), 46.3% had no or mild residual symptoms (MRS < or =1), and 44.6% had no higher cognitive deficits on the EBI. Of the patients who personally answered the follow-up questions, 67% had no major physical disability (SF-36 PF <60), and 32.9% reported symptoms classified as depression (CES-D > or =10). The high percentage of patients reaching the maximum score (ceiling effect) in the BI was less pronounced in the MRS and SF-36 PF. The predictive factors for dichotomized outcomes on each scale were similar for adverse functioning and disability but varied considerably for depression.
To avoid ceiling effects in outcome distribution of patients treated in specialized stroke centers, the MRS and SF-36 PF instruments are preferable to the BI. Parametric use of the SF-36 PF could further improve outcome measurement by considering individual treatment effects.
缺血性卒中后的功能与残疾情况具有临床意义,且对患者至关重要。尽管有多种工具可用于评估这些结局,但对它们之间的相互关系及预测因素却知之甚少。
我们在1998年至1999年的1年时间里,前瞻性地从德国30家医院中确定了4264例急性缺血性卒中患者,并将他们登记在一个公共数据库中。在100天和1年后通过电话访谈对患者进行集中随访,以评估各种量表,如巴氏指数(BI)、改良Rankin量表(MRS)、扩展巴氏指数(EBI)、简短健康调查问卷36项身体功能量表(SF-36 PF)以及流行病学研究中心抑郁量表简表(CES-D)。
入院100天后,67.2%的患者的结局状态可被评估。其中,13.9%的患者死亡,53.7%的患者恢复了功能独立(BI<95),46.3%的患者无或仅有轻微残留症状(MRS≤1),44.6%的患者在EBI上无更高的认知缺陷。在亲自回答随访问题的患者中,67%无严重身体残疾(SF-36 PF<60),32.9%报告有被归类为抑郁的症状(CES-D≥10)。在BI量表中达到最高分(天花板效应)的患者比例较高,而在MRS和SF-36 PF量表中则不太明显。各量表二分结局的预测因素在不良功能和残疾方面相似,但在抑郁方面差异很大。
为避免在专业卒中中心治疗的患者结局分布中出现天花板效应,MRS和SF-36 PF工具比BI更可取。通过考虑个体治疗效果,对SF-36 PF进行参数化使用可进一步改善结局测量。